Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Placebo Controlled Trial of Prometa Pharmacotherapy for the Treatment of Methamphetamine Abuse

NCT00260481 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT00260481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00260481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Placebo Controlled Trial of Prometa Pharmacotherapy for the Treatment of Methamphetamine Abuse
Lead sponsor
University of California, Los Angeles
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2006
Completion date
June 30, 2008
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug abuse, drug dependence